NPTH — NeuPath Health Balance Sheet
0.000.00%
Last trade - 00:00- CA$18.84m
- CA$27.48m
- CA$72.81m
- 55
- 94
- 86
- 93
Annual balance sheet for NeuPath Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 10.8 | 5.9 | 1.52 | 3.18 | 2.92 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 7.84 | 8.47 | 8.89 | 6.87 | 7.67 |
| Total Other Current Assets | |||||
| Total Current Assets | 19.3 | 15.4 | 11.1 | 10.7 | 11.1 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6.63 | 11.6 | 11.5 | 9.07 | 8.21 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 46.1 | 51.3 | 45.1 | 41.8 | 41.3 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9.98 | 13.7 | 13.9 | 9.15 | 15.4 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 18.5 | 25.5 | 23.3 | 19.7 | 19.9 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 27.6 | 25.8 | 21.8 | 22.1 | 21.4 |
| Total Liabilities & Shareholders' Equity | 46.1 | 51.3 | 45.1 | 41.8 | 41.3 |
| Total Common Shares Outstanding |